Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas

OBJECTIVE: The main aim of this study was to evaluate cancer antigen 125 (CA125)/carcinoembryonic antigen (CEA) ratio (CCR), as a reliable marker to differentiate ovarian mucinous carcinoma from other epithelial ovarian carcinomas (EOCs), namely serous, clear cell, and endometrioid carcinomas. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Ji Hui, Sohn, Geum Seon, Chay, Doo Byung, Cho, Han Byoul, Kim, Jae-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956117/
https://www.ncbi.nlm.nih.gov/pubmed/29780776
http://dx.doi.org/10.5468/ogs.2018.61.3.344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956117/
https://www.ncbi.nlm.nih.gov/pubmed/29780776
http://dx.doi.org/10.5468/ogs.2018.61.3.344

Ejemplares similares